OOIR: Observatory of International Research

Papers

(The H4-Index of Haematologica is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.	140
<i>TCF3::HLF</i> acute lymphoblastic leukemia: still challenging to cure thirty years later	100
Non-tuberculous mycobacterial infections in hematology-oncology: we need to look harder	97
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival	97
A <i>Grammastola spatulata</i> mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic etiologies	93
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment	82
Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy	74
Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma	72
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma	70
“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms	66
Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia	64
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high risk smoldering multiple myeloma included in the GEM-CESAR trial	61
Impact of soluble thrombomodulin and activated protein C on dynamic hemostatic function in trauma: a focus on thrombin generation and clot lysis	57
Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy	55
The real world of acute lymphoblastic leukemia	54
B-cell lymphoblastic leukemia/lymphoma with mutated <i>IKZF1</i> N159Y: clinical and genetic features of an emerging entity	53
Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndrome	53
Images from the Haematologica Atlas of Hematologic Cytology: Sézary syndrome	51
Community respiratory viruses are generally well-tolerated in hematopoietic stem cell transplant recipients: a brief report from the TRANSPIRE study	51
Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition	48
Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells	48
Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pedi	47
Temporal changes in erythroid progenitors in critically ill patients: a prospective cohort study	47
Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?	46
Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies	45

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia	45
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis	43
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with <i>nucleophosmin1</i>-mutated acute myeloid leukemia receiving gemtuzumab oz	42
Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia	42
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation	40
Toward further excellence in <i>Haematologica</i>	40
Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation	38
Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP	36
Improving the treatment of childhood acute lymphoblastic leukemia by optimizing the use of 70-year-old drugs	36
Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets	36
Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal <i>Salmonella</i> bacteremia	36
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies	36